September 9, 2009 - Covidien, a global provider of healthcare products, announced that it has completed the previously announced acquisition of Power Medical Interventions Inc. (PMI) for an aggregate consideration of approximately $65 million, including assumption of debt.

The acquisition of Power Medical will expand Covidien’s stapling product line and solutions that enable advanced surgical care.

The tender offer expired at 12:00 midnight ET, at the end of September 4, 2009. At that time, the depositary for the offer advised Covidien that 15,210,583 shares of PMI had been validly tendered and not withdrawn, representing approximately 87 percent of the outstanding PMI common shares. All shares that were validly tendered and not withdrawn were accepted for purchase and paid for in accordance with the tender offer. An additional 247,765 shares, or approximately 1.4 percent of the outstanding PMI shares, had been tendered pursuant to notices of guaranteed delivery.

For more information: www.covidien.com


Additional Content

News | Lung Imaging

Nov.2, 2026 – SimonMed has announced the clinical launch of two advanced lung imaging technologies, CT:VQ and LDAf, in ...

Time November 02, 2026
arrow
News | Contrast Media

Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...

Time October 28, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Oct. 26, 2026 — Dr. Kathryn Keenan is one of seven public servants from various federal agencies who will be honored at ...

Time October 27, 2026
arrow
News | Radiology Business

Oct. 26, 2026 — RadNet, Inc. has entered into a definitive agreement to acquire ONRAD, Inc., a provider of teleradiology ...

Time October 27, 2026
arrow
News | Lung Imaging

Oct. 23, 2026 — The University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute recently ...

Time October 23, 2026
arrow
Subscribe Now